Literature DB >> 16870773

Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.

Lucas D Tilley1, Orion S Hine, Jill A Kellogg, Jed N Hassinger, Dwight D Weller, Patrick L Iversen, Bruce L Geller.   

Abstract

The objective was to improve efficacy of antisense phosphorodiamidate morpholino oligomers (PMOs) by improving their uptake into bacterial cells. Four different bacterium-permeating peptides, RFFRFFRFFXB, RTRTRFLRRTXB, RXXRXXRXXB, and KFFKFFKFFKXB (X is 6-aminohexanoic acid and B is beta-alanine), were separately coupled to two different PMOs that are complementary to regions near the start codons of a luciferase reporter gene (luc) and a gene required for viability (acpP). Luc peptide-PMOs targeted to luc inhibited luciferase activity 23 to 80% in growing cultures of Escherichia coli. In cell-free translation reactions, Luc RTRTRFLRRTXB-PMO inhibited luciferase synthesis significantly more than the other Luc peptide-PMOs or the Luc PMO not coupled to peptide. AcpP peptide-PMOs targeted to acpP inhibited growth of E. coli or Salmonella enterica serovar Typhimurium to various extents, depending on the strain. The concentrations of AcpP RFFRFFRFFXB-PMO, AcpP RTRTRFLRRTXB-PMO, AcpP KFFKFFKFFKXB-PMO, and ampicillin that reduced CFU/ml by 50% after 8 h of growth (50% inhibitory concentration [IC(50)]) were 3.6, 10.8, 9.5, and 7.5 microM, respectively, in E. coli W3110. Sequence-specific effects of AcpP peptide-PMOs were shown by rescuing growth of a merodiploid strain that expressed acpP with silent mutations in the region targeted by AcpP peptide-PMO. In Caco-2 cultures infected with enteropathogenic E. coli (EPEC), 10 microM AcpP RTRTRFLRRTXB-PMO or AcpP RFFRFFRFFXB-PMO essentially cleared the infection. The IC(50) of either AcpP RTRTRFLRRTXB-PMO or AcpP RFFRFFRFFXB-PMO in EPEC-infected Caco-2 culture was 3 microM. In summary, RFFRFFRFFXB, RTRTRFLRRTXB, or KFFKFFKFFXB, when covalently bonded to PMO, significantly increased inhibition of expression of targeted genes compared to PMOs without attached peptide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16870773      PMCID: PMC1538669          DOI: 10.1128/AAC.01286-05

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

Review 1.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

2.  Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids.

Authors:  Natalia Nekhotiaeva; Satish Kumar Awasthi; Peter E Nielsen; Liam Good
Journal:  Mol Ther       Date:  2004-10       Impact factor: 11.454

3.  Polar allele duplication for transcriptional analysis of consecutive essential genes: application to a cluster of Escherichia coli fatty acid biosynthetic genes.

Authors:  Y Zhang; J E Cronan
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

4.  Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection.

Authors:  Xin-Xing Tan; Jeffrey K Actor; Yin Chen
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 5.  Morpholino antisense oligomers: design, preparation, and properties.

Authors:  J Summerton; D Weller
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-06

Review 6.  Transport across the bacterial outer membrane.

Authors:  H Nikaido
Journal:  J Bioenerg Biomembr       Date:  1993-12       Impact factor: 2.945

7.  Bactericidal antisense effects of peptide-PNA conjugates.

Authors:  L Good; S K Awasthi; R Dryselius; O Larsson; P E Nielsen
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

8.  Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.

Authors:  M Vaara; M Porro
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  A mutant of Escherichia coli conditionally defective in the synthesis of holo-[acyl carrier protein].

Authors:  M L Polacco; J E Cronan
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

10.  Ratio of active to inactive forms of acyl carrier protein in Escherichia coli.

Authors:  S Jackowski; C O Rock
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

View more
  27 in total

Review 1.  Fighting against evolution of antibiotic resistance by utilizing evolvable antimicrobial drugs.

Authors:  Mehmet Fatih Cansizoglu; Erdal Toprak
Journal:  Curr Genet       Date:  2017-05-11       Impact factor: 3.886

2.  Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.

Authors:  Erin K Sully; Bruce L Geller; Lixin Li; Christina M Moody; Stacey M Bailey; Amy L Moore; Michael Wong; Patrice Nordmann; Seth M Daly; Carolyn R Sturge; David E Greenberg
Journal:  J Antimicrob Chemother       Date:  2017-03-01       Impact factor: 5.790

3.  Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.

Authors:  Taketo Otsuka; Aimee L Brauer; Charmaine Kirkham; Erin K Sully; Melinda M Pettigrew; Yong Kong; Bruce L Geller; Timothy F Murphy
Journal:  J Antimicrob Chemother       Date:  2016-09-28       Impact factor: 5.790

4.  Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

Authors:  David E Greenberg; Kimberly R Marshall-Batty; Lauren R Brinster; Kol A Zarember; Pamela A Shaw; Brett L Mellbye; Patrick L Iversen; Steven M Holland; Bruce L Geller
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 5.  Advances in therapeutic bacterial antisense biotechnology.

Authors:  John P Hegarty; David B Stewart
Journal:  Appl Microbiol Biotechnol       Date:  2017-12-05       Impact factor: 4.813

6.  Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.

Authors:  James J Howard; Carolyn R Sturge; Dina A Moustafa; Seth M Daly; Kimberly R Marshall-Batty; Christina F Felder; Danniel Zamora; Marium Yabe-Gill; Maria Labandeira-Rey; Stacey M Bailey; Michael Wong; Joanna B Goldberg; Bruce L Geller; David E Greenberg
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

7.  Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.

Authors:  Rekha G Panchal; Bruce L Geller; Brett Mellbye; Douglas Lane; Patrick L Iversen; Sina Bavari
Journal:  Nucleic Acid Ther       Date:  2012-09-14       Impact factor: 5.486

8.  Morpholino oligomers tested in vitro, in biofilm and in vivo against multidrug-resistant Klebsiella pneumoniae.

Authors:  Bruce L Geller; Lixin Li; Fabian Martinez; Erin Sully; Carolyn R Sturge; Seth M Daly; Christine Pybus; David E Greenberg
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

9.  Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.

Authors:  Susan E Puckett; Kaleb A Reese; Georgi M Mitev; Valerie Mullen; Rudd C Johnson; Kyle R Pomraning; Brett L Mellbye; Lucas D Tilley; Patrick L Iversen; Michael Freitag; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2012-09-17       Impact factor: 5.191

10.  DNA mimics for the rapid identification of microorganisms by fluorescence in situ hybridization (FISH).

Authors:  Laura Cerqueira; Nuno F Azevedo; Carina Almeida; Tatiana Jardim; Charles William Keevil; Maria J Vieira
Journal:  Int J Mol Sci       Date:  2008-10-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.